Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiguang Zhang

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
The Lancet. Oncology|June 2, 2020
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort studyKunyu Yang, Yuhan Sheng, Chaolin Huang, et al.
Med (New York, N.Y.)|February 1, 2025
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trialLiang Zeng, Huan Yan, Wenjuan Jiang, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancerLiang Zeng, Fan Tong, Xingxiang Xu, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
The Lancet. Oncology|June 2, 2020
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort studyKunyu Yang, Yuhan Sheng, Chaolin Huang, et al.
Med (New York, N.Y.)|February 1, 2025
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trialLiang Zeng, Huan Yan, Wenjuan Jiang, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancerLiang Zeng, Fan Tong, Xingxiang Xu, et al.
Pageof 7